Abera Bioscience ABStockholm
LEI 549300IO3Q8IE2FDUS29 · XSTO · SE · Business ID 5569090904
Recent insider sentiment
Net buying — last 90 days
SEK 328,000.00 boughtNo sales
Share-award batches are excluded from this read — they’re compensation, not conviction.
1
Open-market buys (90d)
0
Sales (90d)
0
Share awards (90d)
2
Active insiders (90d)
Transactions
| Date | Person | Nature | Volume | Price | Value | Source |
|---|---|---|---|---|---|---|
| 20.07.2026 | Maria Alriksson — CEO | New shares (subscription) | 40,000 | SEK 8.20 | SEK 328,000.00 | ↗ |
| 20.07.2026 | Mats Lundgren — Management | Bought — open marketAcquisition | 40,000 | SEK 8.20 | SEK 328,000.00 | ↗ |
Active insiders (90d)
40,000 shares
1 filing
Mats Lundgren
Management
40,000 shares
1 filing